Skip to content
★ Sign in to follow
NS

Nusrath Sultana

Board Director
Director
Surmodics IncSurmodics Inc
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 14 Feb 2022 for SURMODICS INC, €28k.

Insider track record

Disclosed buys
0
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Nusrath Sultana: trading record in brief

Nusrath Sultana (board member) discloses dealings in Surmodics Inc to SEC (Form 4). The record holds 6 filings, for trades running from 12 February 2020 to 12 February 2022.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 14 February 2022 came the latest disclosure, a share grant for €28k in Surmodics Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Nusrath Sultana

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ◆
    VP, Clinical AffairsExecutivesSurmodics Inc
    31,753 USD17SEC
    762 shares@ US$41.6762.4% of flowCommon StockSEC:0001209191-22-009314:0
  • ◆
    VP, Clinical AffairsExecutivesSurmodics Inc
    18,934 USD15SEC
    431 shares@ US$43.9337.6% of flowCommon StockSEC:0001209191-21-067524:0

2 of 2 declarations